Intrahepatic cholestasis of pregnancy has no effect on maternal serum second trimester alpha-fetoprotein and hCG

Acta Obstetricia et Gynecologica Scandinavica

Volumn 79, Issue 7, 2000, Pages 548-552

  Eloranta, Marja Liisa ^b   Heinonen, Seppo ^a   Kirkinen, Pertti ^b  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b NONE

Author keywords

Down's syndrome; Intrahepatic cholestasis; Serum screening

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN SYNDROME; FEMALE; HUMAN; INTRAHEPATIC CHOLESTASIS; MAJOR CLINICAL STUDY; MATERNAL AGE; NEWBORN; PREGNANCY; PRENATAL SCREENING; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY;

ADULT; ALPHA-FETOPROTEINS; CHOLESTASIS, INTRAHEPATIC; CHORIONIC GONADOTROPIN; DIAGNOSIS, DIFFERENTIAL; DOWN SYNDROME; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PRENATAL DIAGNOSIS;

EID: 0033946544     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0412.2000.079007548.x     Document Type: Article

References (15)

1. 1. Wald NJ, Cuckle HS, Densem JW, Nanchah K, Royston P, Chard T et al. Maternal serum screening for Down's syndrome in early pregnancy. BMJ 1988; 297: 883-7.
2. 2. Gravett CP, Buckmaster JG, Watson PT, Gravett MG. Elevated second trimester maternal serum β-hCG concentrations and subsequent adverse pregnancy outcome. Am J Med Genet 1992; 44: 485-6.
3. 3. Wenström KD, Owen J, Boots LR, DuBard MB. Elevated second-trimester human chorionic gonadotropin levels in association with poor pregnancy outcome. Am J Obstet Gynecol 1994; 171: 1038-41.
4. 4. Lieppman RE, Williams MA, Cheng EY, Resta R, Zingheim R, Hickok DE et al. An association between elevated levels of human chorionic gonadotropin in the midtrimester and adverse pregnancy outcome. Am J Obstet Gynecol 1993; 168: 1852-7.
5. 5. Fisk NM, Sotrey GN. Fetal outcome in obstetric cholestasis. Br J Obstet Gynaecol 1988; 95: 1137-43.
6. 6. Alsulyman OM, Ouzounian JG, Ames-Castro M, Goodwin TM. Intrahepatic cholestasis of pregnancy: perinatal outcome associated with expectant management. Am J Obstet Gynecol 1996; 175: 957-60.
7. 7. Rioseco AJ, Ivankovic MB, Manzur A, Hamed F, Kato SR, Parer JT et al. Intrahepatic cholestasis of pregnancy: a retrospective case-control study of perinatal outcome. Am J Obstet Gynecol 1994; 170: 890-5.
8. 8. Johnson P, Samisoe G, Gustafson A. Studies in cholestasis of pregnancy with special reference to clinical aspects and liver function tests. Acta Obstet Gynecol Scand (Suppl) 1975; 123: 823-8.
9. 9. Morssink LP, Heringa MR Beekhuis JR, De Wolf BT, Mantingh A. The HELLP syndrome: its association with unexplained elevation of MSAFP and MShCG in the second trimester. Prenat Diagn 1997; 17: 601-6.
10. 10. Germa JR, Llanos M, Tabernero JM, Mora J. False elevations of alpha-fetoprotein associated with liver dysfunction in germ cell tumors. Cancer 1993; 15: 2491-4.
11. 11. Monte MJ, Morales AI, Arevalo M, Alvaro I, Macias RI, Marin JJ. Reversible impairment of neonatal hepatobiliary function by maternal cholestasis. Hepatology 1996; 23: 1208-17.
12. 12. Midgley DY, Khalaf Y, Braude PR, Nelson-Piercy C. Recurrent cholestasis following ovarian hyperstimulation: case report. Hum Reprod 1999; 14: 2249-51.
13. 13. Penttilä IM, Ryynänen M, Hämäläinen E, Puhakainen E, Savolainen K. Quality specifications for S-AFP and S-hCG-□ determinations for screening of fetal abnormalities. Ups J Med Sci 1993; 98: 375-80.
14. 14. Reyes H, Simon FR. Intrahepatic cholestasis of pregnancy: an estrogen-related disease. Semin Liver Dis 1993; 13: 289-301.
15. 15. Berg B, Helm G, Petersohn L, Tryrding N. Cholestasis of pregnancy: clinical and laboratory studies. Acta Obstet Gynecol Scand 1986; 65: 107-13.